nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—Vitreous floaters—Varenicline—nicotine dependence	0.036	0.0762	CcSEcCtD
Dexamethasone—Cataract subcapsular—Varenicline—nicotine dependence	0.0313	0.0663	CcSEcCtD
Dexamethasone—Withdrawal symptom—Varenicline—nicotine dependence	0.0199	0.0422	CcSEcCtD
Dexamethasone—Pancreatitis acute—Varenicline—nicotine dependence	0.0177	0.0375	CcSEcCtD
Dexamethasone—CYP3A43—Xenobiotics—CYP2A7—nicotine dependence	0.0175	0.0436	CbGpPWpGaD
Dexamethasone—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.0167	0.0353	CcSEcCtD
Dexamethasone—CYP4A11—Fatty acids—CYP2A7—nicotine dependence	0.0153	0.038	CbGpPWpGaD
Dexamethasone—Osteoporosis—Varenicline—nicotine dependence	0.0146	0.0309	CcSEcCtD
Dexamethasone—Suicidal ideation—Varenicline—nicotine dependence	0.0116	0.0247	CcSEcCtD
Dexamethasone—Delusion—Varenicline—nicotine dependence	0.0115	0.0244	CcSEcCtD
Dexamethasone—PLA2G1B—cardiovascular system—nicotine dependence	0.0113	0.0894	CbGeAlD
Dexamethasone—Mania—Varenicline—nicotine dependence	0.0112	0.0238	CcSEcCtD
Dexamethasone—Fungal infection—Varenicline—nicotine dependence	0.0106	0.0224	CcSEcCtD
Dexamethasone—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0104	0.026	CbGpPWpGaD
Dexamethasone—Glycosuria—Varenicline—nicotine dependence	0.0101	0.0214	CcSEcCtD
Dexamethasone—Acne—Varenicline—nicotine dependence	0.00971	0.0206	CcSEcCtD
Dexamethasone—Leukocytosis—Varenicline—nicotine dependence	0.00869	0.0184	CcSEcCtD
Dexamethasone—ANXA1—cardiovascular system—nicotine dependence	0.00861	0.0684	CbGeAlD
Dexamethasone—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00842	0.0209	CbGpPWpGaD
Dexamethasone—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00825	0.0205	CbGpPWpGaD
Dexamethasone—NR0B1—brain—nicotine dependence	0.00776	0.0616	CbGeAlD
Dexamethasone—Dry eye—Varenicline—nicotine dependence	0.00754	0.016	CcSEcCtD
Dexamethasone—Oesophagitis—Varenicline—nicotine dependence	0.00746	0.0158	CcSEcCtD
Dexamethasone—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00727	0.0181	CbGpPWpGaD
Dexamethasone—CYP3A43—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00718	0.0179	CbGpPWpGaD
Dexamethasone—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00713	0.0177	CbGpPWpGaD
Dexamethasone—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00706	0.0176	CbGpPWpGaD
Dexamethasone—Euphoric mood—Varenicline—nicotine dependence	0.00702	0.0149	CcSEcCtD
Dexamethasone—Diabetes mellitus—Varenicline—nicotine dependence	0.00682	0.0144	CcSEcCtD
Dexamethasone—ANXA1—midbrain—nicotine dependence	0.00673	0.0534	CbGeAlD
Dexamethasone—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00657	0.0163	CbGpPWpGaD
Dexamethasone—Eye pain—Varenicline—nicotine dependence	0.00657	0.0139	CcSEcCtD
Dexamethasone—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00647	0.0161	CbGpPWpGaD
Dexamethasone—Injury—Varenicline—nicotine dependence	0.00645	0.0137	CcSEcCtD
Dexamethasone—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00636	0.0158	CbGpPWpGaD
Dexamethasone—Increased appetite—Varenicline—nicotine dependence	0.00631	0.0134	CcSEcCtD
Dexamethasone—Visual disturbance—Varenicline—nicotine dependence	0.00626	0.0133	CcSEcCtD
Dexamethasone—Lethargy—Varenicline—nicotine dependence	0.00605	0.0128	CcSEcCtD
Dexamethasone—Osteoarthritis—Varenicline—nicotine dependence	0.00593	0.0126	CcSEcCtD
Dexamethasone—CYP3A43—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0059	0.0147	CbGpPWpGaD
Dexamethasone—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00585	0.0146	CbGpPWpGaD
Dexamethasone—Affect lability—Varenicline—nicotine dependence	0.00584	0.0124	CcSEcCtD
Dexamethasone—Migraine—Varenicline—nicotine dependence	0.00584	0.0124	CcSEcCtD
Dexamethasone—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0058	0.0144	CbGpPWpGaD
Dexamethasone—Psychotic disorder—Varenicline—nicotine dependence	0.00579	0.0123	CcSEcCtD
Dexamethasone—Irritability—Varenicline—nicotine dependence	0.00566	0.012	CcSEcCtD
Dexamethasone—Mood swings—Varenicline—nicotine dependence	0.00562	0.0119	CcSEcCtD
Dexamethasone—NR3C2—cardiovascular system—nicotine dependence	0.00558	0.0443	CbGeAlD
Dexamethasone—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00557	0.0139	CbGpPWpGaD
Dexamethasone—PLA2G1B—brain—nicotine dependence	0.00553	0.0439	CbGeAlD
Dexamethasone—CYP17A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0055	0.0137	CbGpPWpGaD
Dexamethasone—Dry skin—Varenicline—nicotine dependence	0.00543	0.0115	CcSEcCtD
Dexamethasone—Hypokalaemia—Varenicline—nicotine dependence	0.0054	0.0114	CcSEcCtD
Dexamethasone—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00522	0.013	CbGpPWpGaD
Dexamethasone—PGR—cardiovascular system—nicotine dependence	0.00518	0.0412	CbGeAlD
Dexamethasone—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00511	0.0127	CbGpPWpGaD
Dexamethasone—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0051	0.0127	CbGpPWpGaD
Dexamethasone—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00509	0.0127	CbGpPWpGaD
Dexamethasone—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00504	0.0125	CbGpPWpGaD
Dexamethasone—CYP11A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00503	0.0125	CbGpPWpGaD
Dexamethasone—CYP4A11—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00498	0.0124	CbGpPWpGaD
Dexamethasone—ANXA1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0049	0.0122	CbGpPWpGaD
Dexamethasone—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00482	0.012	CbGpPWpGaD
Dexamethasone—Weight increased—Varenicline—nicotine dependence	0.00466	0.00988	CcSEcCtD
Dexamethasone—Hyperglycaemia—Varenicline—nicotine dependence	0.00462	0.00979	CcSEcCtD
Dexamethasone—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00457	0.0114	CbGpPWpGaD
Dexamethasone—CYP17A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00451	0.0112	CbGpPWpGaD
Dexamethasone—Acute coronary syndrome—Varenicline—nicotine dependence	0.0045	0.00954	CcSEcCtD
Dexamethasone—Myocardial infarction—Varenicline—nicotine dependence	0.00448	0.00949	CcSEcCtD
Dexamethasone—Conjunctivitis—Varenicline—nicotine dependence	0.00444	0.00941	CcSEcCtD
Dexamethasone—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00442	0.011	CbGpPWpGaD
Dexamethasone—CYP1B1—cardiovascular system—nicotine dependence	0.00436	0.0346	CbGeAlD
Dexamethasone—NR3C2—midbrain—nicotine dependence	0.00436	0.0346	CbGeAlD
Dexamethasone—ANXA1—brain—nicotine dependence	0.00423	0.0336	CbGeAlD
Dexamethasone—Bradycardia—Varenicline—nicotine dependence	0.00418	0.00885	CcSEcCtD
Dexamethasone—CYP11A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00413	0.0103	CbGpPWpGaD
Dexamethasone—CYP4A11—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00409	0.0102	CbGpPWpGaD
Dexamethasone—Hallucination—Varenicline—nicotine dependence	0.00408	0.00865	CcSEcCtD
Dexamethasone—Visual impairment—Varenicline—nicotine dependence	0.00395	0.00837	CcSEcCtD
Dexamethasone—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00394	0.00981	CbGpPWpGaD
Dexamethasone—Eye disorder—Varenicline—nicotine dependence	0.00383	0.00812	CcSEcCtD
Dexamethasone—CYP17A1—brain—nicotine dependence	0.00379	0.0301	CbGeAlD
Dexamethasone—SLCO1A2—midbrain—nicotine dependence	0.00373	0.0296	CbGeAlD
Dexamethasone—Angiopathy—Varenicline—nicotine dependence	0.00372	0.00788	CcSEcCtD
Dexamethasone—Arrhythmia—Varenicline—nicotine dependence	0.00366	0.00776	CcSEcCtD
Dexamethasone—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00363	0.00902	CbGpPWpGaD
Dexamethasone—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0036	0.00894	CbGpPWpGaD
Dexamethasone—Erythema—Varenicline—nicotine dependence	0.00357	0.00756	CcSEcCtD
Dexamethasone—CYP11A1—brain—nicotine dependence	0.00352	0.028	CbGeAlD
Dexamethasone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00337	0.00839	CbGpPWpGaD
Dexamethasone—CYP19A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00333	0.00828	CbGpPWpGaD
Dexamethasone—CYP3A43—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00332	0.00827	CbGpPWpGaD
Dexamethasone—Ill-defined disorder—Varenicline—nicotine dependence	0.00331	0.00702	CcSEcCtD
Dexamethasone—Angioedema—Varenicline—nicotine dependence	0.00326	0.00691	CcSEcCtD
Dexamethasone—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00325	0.00808	CbGpPWpGaD
Dexamethasone—Malaise—Varenicline—nicotine dependence	0.00322	0.00682	CcSEcCtD
Dexamethasone—Vertigo—Varenicline—nicotine dependence	0.00321	0.0068	CcSEcCtD
Dexamethasone—CYP1B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00321	0.00798	CbGpPWpGaD
Dexamethasone—Syncope—Varenicline—nicotine dependence	0.0032	0.00678	CcSEcCtD
Dexamethasone—Loss of consciousness—Varenicline—nicotine dependence	0.00314	0.00665	CcSEcCtD
Dexamethasone—CYP3A43—Biological oxidations—CYP2A7—nicotine dependence	0.00313	0.00779	CbGpPWpGaD
Dexamethasone—Convulsion—Varenicline—nicotine dependence	0.00309	0.00655	CcSEcCtD
Dexamethasone—CYP3A43—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00309	0.00768	CbGpPWpGaD
Dexamethasone—Hypertension—Varenicline—nicotine dependence	0.00308	0.00653	CcSEcCtD
Dexamethasone—Myalgia—Varenicline—nicotine dependence	0.00304	0.00644	CcSEcCtD
Dexamethasone—Anxiety—Varenicline—nicotine dependence	0.00303	0.00642	CcSEcCtD
Dexamethasone—Discomfort—Varenicline—nicotine dependence	0.003	0.00636	CcSEcCtD
Dexamethasone—CYP2B6—cardiovascular system—nicotine dependence	0.003	0.0238	CbGeAlD
Dexamethasone—NR3C1—cardiovascular system—nicotine dependence	0.00299	0.0238	CbGeAlD
Dexamethasone—ANXA1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00297	0.00738	CbGpPWpGaD
Dexamethasone—CYP2C9—cardiovascular system—nicotine dependence	0.00297	0.0236	CbGeAlD
Dexamethasone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00293	0.00729	CbGpPWpGaD
Dexamethasone—CYP2A6—brain—nicotine dependence	0.00292	0.0232	CbGeAlD
Dexamethasone—Oedema—Varenicline—nicotine dependence	0.00291	0.00617	CcSEcCtD
Dexamethasone—Infection—Varenicline—nicotine dependence	0.00289	0.00613	CcSEcCtD
Dexamethasone—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00289	0.00719	CbGpPWpGaD
Dexamethasone—Shock—Varenicline—nicotine dependence	0.00287	0.00607	CcSEcCtD
Dexamethasone—Nervous system disorder—Varenicline—nicotine dependence	0.00286	0.00605	CcSEcCtD
Dexamethasone—Thrombocytopenia—Varenicline—nicotine dependence	0.00285	0.00604	CcSEcCtD
Dexamethasone—Tachycardia—Varenicline—nicotine dependence	0.00284	0.00602	CcSEcCtD
Dexamethasone—Hyperhidrosis—Varenicline—nicotine dependence	0.00282	0.00597	CcSEcCtD
Dexamethasone—CYP2E1—cardiovascular system—nicotine dependence	0.00281	0.0223	CbGeAlD
Dexamethasone—Anorexia—Varenicline—nicotine dependence	0.00278	0.00588	CcSEcCtD
Dexamethasone—NR3C2—brain—nicotine dependence	0.00274	0.0217	CbGeAlD
Dexamethasone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00274	0.0068	CbGpPWpGaD
Dexamethasone—Hypotension—Varenicline—nicotine dependence	0.00272	0.00577	CcSEcCtD
Dexamethasone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00269	0.00668	CbGpPWpGaD
Dexamethasone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00265	0.00562	CcSEcCtD
Dexamethasone—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00265	0.00659	CbGpPWpGaD
Dexamethasone—Insomnia—Varenicline—nicotine dependence	0.00264	0.00558	CcSEcCtD
Dexamethasone—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00263	0.00655	CbGpPWpGaD
Dexamethasone—PTGS2—cardiovascular system—nicotine dependence	0.00259	0.0206	CbGeAlD
Dexamethasone—Dyspepsia—Varenicline—nicotine dependence	0.00256	0.00543	CcSEcCtD
Dexamethasone—CYP17A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00254	0.00633	CbGpPWpGaD
Dexamethasone—PGR—brain—nicotine dependence	0.00254	0.0202	CbGeAlD
Dexamethasone—ABCG2—midbrain—nicotine dependence	0.00254	0.0201	CbGeAlD
Dexamethasone—Decreased appetite—Varenicline—nicotine dependence	0.00253	0.00537	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00252	0.00533	CcSEcCtD
Dexamethasone—Fatigue—Varenicline—nicotine dependence	0.00251	0.00532	CcSEcCtD
Dexamethasone—Pain—Varenicline—nicotine dependence	0.00249	0.00528	CcSEcCtD
Dexamethasone—ANXA1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00245	0.00609	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Varenicline—nicotine dependence	0.0024	0.00509	CcSEcCtD
Dexamethasone—CYP17A1—Biological oxidations—CYP2A7—nicotine dependence	0.0024	0.00597	CbGpPWpGaD
Dexamethasone—Gastrointestinal pain—Varenicline—nicotine dependence	0.00238	0.00505	CcSEcCtD
Dexamethasone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00238	0.00591	CbGpPWpGaD
Dexamethasone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00237	0.0059	CbGpPWpGaD
Dexamethasone—CYP17A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00237	0.00588	CbGpPWpGaD
Dexamethasone—SLCO1A2—brain—nicotine dependence	0.00235	0.0186	CbGeAlD
Dexamethasone—NR3C1—midbrain—nicotine dependence	0.00234	0.0185	CbGeAlD
Dexamethasone—CYP11A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00233	0.00579	CbGpPWpGaD
Dexamethasone—Urticaria—Varenicline—nicotine dependence	0.00231	0.0049	CcSEcCtD
Dexamethasone—Abdominal pain—Varenicline—nicotine dependence	0.0023	0.00488	CcSEcCtD
Dexamethasone—Body temperature increased—Varenicline—nicotine dependence	0.0023	0.00488	CcSEcCtD
Dexamethasone—CYP19A1—brain—nicotine dependence	0.00229	0.0182	CbGeAlD
Dexamethasone—CYP11A1—Biological oxidations—CYP2A7—nicotine dependence	0.00219	0.00546	CbGpPWpGaD
Dexamethasone—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00218	0.00542	CbGpPWpGaD
Dexamethasone—CYP4A11—Biological oxidations—CYP2A7—nicotine dependence	0.00217	0.0054	CbGpPWpGaD
Dexamethasone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00217	0.00539	CbGpPWpGaD
Dexamethasone—CYP11A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00216	0.00538	CbGpPWpGaD
Dexamethasone—CYP1B1—brain—nicotine dependence	0.00214	0.017	CbGeAlD
Dexamethasone—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00214	0.00532	CbGpPWpGaD
Dexamethasone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00212	0.00528	CbGpPWpGaD
Dexamethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00212	0.00527	CbGpPWpGaD
Dexamethasone—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00209	0.00521	CbGpPWpGaD
Dexamethasone—Asthenia—Varenicline—nicotine dependence	0.00209	0.00443	CcSEcCtD
Dexamethasone—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00209	0.0052	CbGpPWpGaD
Dexamethasone—ANXA1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00207	0.00514	CbGpPWpGaD
Dexamethasone—Pruritus—Varenicline—nicotine dependence	0.00206	0.00437	CcSEcCtD
Dexamethasone—PTGS2—midbrain—nicotine dependence	0.00202	0.0161	CbGeAlD
Dexamethasone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.002	0.00498	CbGpPWpGaD
Dexamethasone—Diarrhoea—Varenicline—nicotine dependence	0.00199	0.00422	CcSEcCtD
Dexamethasone—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00197	0.00491	CbGpPWpGaD
Dexamethasone—Dizziness—Varenicline—nicotine dependence	0.00193	0.00408	CcSEcCtD
Dexamethasone—Vomiting—Varenicline—nicotine dependence	0.00185	0.00392	CcSEcCtD
Dexamethasone—Rash—Varenicline—nicotine dependence	0.00184	0.00389	CcSEcCtD
Dexamethasone—Dermatitis—Varenicline—nicotine dependence	0.00184	0.00389	CcSEcCtD
Dexamethasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00183	0.00456	CbGpPWpGaD
Dexamethasone—Headache—Varenicline—nicotine dependence	0.00183	0.00387	CcSEcCtD
Dexamethasone—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00181	0.0045	CbGpPWpGaD
Dexamethasone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00176	0.00437	CbGpPWpGaD
Dexamethasone—Nausea—Varenicline—nicotine dependence	0.00173	0.00367	CcSEcCtD
Dexamethasone—NOS2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00173	0.00429	CbGpPWpGaD
Dexamethasone—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00172	0.00428	CbGpPWpGaD
Dexamethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00172	0.00427	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00168	0.00417	CbGpPWpGaD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00164	0.00409	CbGpPWpGaD
Dexamethasone—CYP2C8—brain—nicotine dependence	0.00164	0.013	CbGeAlD
Dexamethasone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00164	0.00407	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—CCAR1—nicotine dependence	0.00163	0.00405	CbGpPWpGaD
Dexamethasone—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00162	0.00403	CbGpPWpGaD
Dexamethasone—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00162	0.00402	CbGpPWpGaD
Dexamethasone—ABCB1—cardiovascular system—nicotine dependence	0.0016	0.0127	CbGeAlD
Dexamethasone—ABCG2—brain—nicotine dependence	0.00159	0.0127	CbGeAlD
Dexamethasone—CYP19A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00154	0.00383	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00152	0.00379	CbGpPWpGaD
Dexamethasone—CYP1A1—brain—nicotine dependence	0.00151	0.012	CbGeAlD
Dexamethasone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00151	0.00375	CbGpPWpGaD
Dexamethasone—ANXA1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00149	0.00372	CbGpPWpGaD
Dexamethasone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00149	0.00371	CbGpPWpGaD
Dexamethasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00149	0.0037	CbGpPWpGaD
Dexamethasone—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00149	0.0037	CbGpPWpGaD
Dexamethasone—CYP1B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00148	0.00369	CbGpPWpGaD
Dexamethasone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00147	0.00366	CbGpPWpGaD
Dexamethasone—CYP2B6—brain—nicotine dependence	0.00147	0.0117	CbGeAlD
Dexamethasone—NR3C1—brain—nicotine dependence	0.00147	0.0117	CbGeAlD
Dexamethasone—CYP19A1—Biological oxidations—CYP2A7—nicotine dependence	0.00145	0.00361	CbGpPWpGaD
Dexamethasone—CYP19A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00143	0.00356	CbGpPWpGaD
Dexamethasone—CYP1B1—Biological oxidations—CYP2A7—nicotine dependence	0.0014	0.00348	CbGpPWpGaD
Dexamethasone—CYP1B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00138	0.00343	CbGpPWpGaD
Dexamethasone—CYP2E1—brain—nicotine dependence	0.00138	0.011	CbGeAlD
Dexamethasone—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00134	0.00333	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00133	0.0033	CbGpPWpGaD
Dexamethasone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00133	0.0033	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—FGD1—nicotine dependence	0.00132	0.00327	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—DRD2—nicotine dependence	0.00128	0.00318	CbGpPWpGaD
Dexamethasone—PTGS2—brain—nicotine dependence	0.00127	0.0101	CbGeAlD
Dexamethasone—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00126	0.00314	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—OPRM1—nicotine dependence	0.00125	0.00311	CbGpPWpGaD
Dexamethasone—ABCB1—midbrain—nicotine dependence	0.00125	0.00993	CbGeAlD
Dexamethasone—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00124	0.0031	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—CCAR1—nicotine dependence	0.00124	0.00309	CbGpPWpGaD
Dexamethasone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00122	0.00304	CbGpPWpGaD
Dexamethasone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00121	0.00301	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—FGD1—nicotine dependence	0.00119	0.00297	CbGpPWpGaD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00119	0.00295	CbGpPWpGaD
Dexamethasone—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00116	0.00288	CbGpPWpGaD
Dexamethasone—CYP2D6—brain—nicotine dependence	0.00109	0.00867	CbGeAlD
Dexamethasone—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00099	0.00246	CbGpPWpGaD
Dexamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000985	0.00245	CbGpPWpGaD
Dexamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000972	0.00242	CbGpPWpGaD
Dexamethasone—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00097	0.00241	CbGpPWpGaD
Dexamethasone—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000968	0.00241	CbGpPWpGaD
Dexamethasone—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000933	0.00232	CbGpPWpGaD
Dexamethasone—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00092	0.00229	CbGpPWpGaD
Dexamethasone—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000914	0.00227	CbGpPWpGaD
Dexamethasone—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.000914	0.00227	CbGpPWpGaD
Dexamethasone—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000912	0.00227	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—DRD2—nicotine dependence	0.000904	0.00225	CbGpPWpGaD
Dexamethasone—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000901	0.00224	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TAS2R16—nicotine dependence	0.0009	0.00224	CbGpPWpGaD
Dexamethasone—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0009	0.00224	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000886	0.0022	CbGpPWpGaD
Dexamethasone—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000862	0.00214	CbGpPWpGaD
Dexamethasone—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00085	0.00211	CbGpPWpGaD
Dexamethasone—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000838	0.00208	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000805	0.002	CbGpPWpGaD
Dexamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000798	0.00199	CbGpPWpGaD
Dexamethasone—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00079	0.00196	CbGpPWpGaD
Dexamethasone—ABCB1—brain—nicotine dependence	0.000786	0.00624	CbGeAlD
Dexamethasone—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000779	0.00194	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—CCAR1—nicotine dependence	0.000756	0.00188	CbGpPWpGaD
Dexamethasone—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000748	0.00186	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000707	0.00176	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FGD1—nicotine dependence	0.000706	0.00176	CbGpPWpGaD
Dexamethasone—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000705	0.00175	CbGpPWpGaD
Dexamethasone—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000695	0.00173	CbGpPWpGaD
Dexamethasone—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000688	0.00171	CbGpPWpGaD
Dexamethasone—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000682	0.0017	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—CYP2A7—nicotine dependence	0.00068	0.00169	CbGpPWpGaD
Dexamethasone—NOS2—Disease—AKR1B10—nicotine dependence	0.000672	0.00167	CbGpPWpGaD
Dexamethasone—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000649	0.00161	CbGpPWpGaD
Dexamethasone—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000643	0.0016	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—OPRM1—nicotine dependence	0.000642	0.0016	CbGpPWpGaD
Dexamethasone—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00064	0.00159	CbGpPWpGaD
Dexamethasone—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000634	0.00158	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AKR1B10—nicotine dependence	0.000623	0.00155	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000587	0.00146	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CYP2A7—nicotine dependence	0.000536	0.00133	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000534	0.00133	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—DRD2—nicotine dependence	0.000511	0.00127	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TAS2R16—nicotine dependence	0.000492	0.00122	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000465	0.00116	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—DRD2—nicotine dependence	0.000464	0.00115	CbGpPWpGaD
Dexamethasone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00045	0.00112	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—WASF2—nicotine dependence	0.000439	0.00109	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—CCAR1—nicotine dependence	0.000437	0.00109	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000424	0.00105	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—WASF1—nicotine dependence	0.000421	0.00105	CbGpPWpGaD
Dexamethasone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000418	0.00104	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CYP2A7—nicotine dependence	0.00041	0.00102	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FGD1—nicotine dependence	0.000386	0.00096	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—OPRM1—nicotine dependence	0.000379	0.000943	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CYP2A7—nicotine dependence	0.000375	0.000933	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CYP2A7—nicotine dependence	0.000371	0.000924	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKR1B10—nicotine dependence	0.000341	0.000848	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CYP2A7—nicotine dependence	0.000329	0.000819	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CYP2A7—nicotine dependence	0.000275	0.000684	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—DRD2—nicotine dependence	0.000274	0.000682	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000251	0.000625	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CYP2A7—nicotine dependence	0.000248	0.000618	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—WASF2—nicotine dependence	0.00024	0.000597	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CYP2A7—nicotine dependence	0.000239	0.000595	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—WASF1—nicotine dependence	0.00023	0.000573	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000218	0.000541	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000216	0.000537	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKR1B10—nicotine dependence	0.000213	0.00053	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—OPRM1—nicotine dependence	0.000207	0.000516	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000198	0.000492	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CYP2A7—nicotine dependence	0.000166	0.000413	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.00016	0.000397	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000156	0.000389	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000156	0.000388	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—DRD2—nicotine dependence	0.00015	0.000373	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000147	0.000367	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000135	0.000336	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000121	0.0003	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000118	0.000293	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000111	0.000276	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.00011	0.000273	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	7.25e-05	0.00018	CbGpPWpGaD
